WuXi PharmaTech (Cayman) Inc. and TruTag Technologies, Inc. have successfully completed joint testing of TruTag’s on-dose authentication solution. TruTags allow a digital scan of a drug to confirm its authenticity and reveal provenance information such as manufacturing location, dosage, images of packaging, expiration date, supply chain data, and lot or batch number. WuXi and TruTag Technologies entered an alliance in 2014, including an investment by the WuXi Venture Fund in TruTag.
 
Based on the testing,TruTags can be applied to qualifying solid oral dosage form products using a consistent, repeatable process without the need for new equipment or changes in manufacturing processes. TruTags are successfully detected using TruTag’s optical detection device but are not visually identifiable and remain with the tablet for its entire life. Also, the TruTag solution did not affect the stability or dissolution properties of API drugs in completed accelerated open and closed bottle testing.
 
WuXi and TruTag will now begin further testing of TruTags on additional API products. TruTag is currently working with several global pharmaceutical companies in pilot testing for broad deployment of this technology in marketed drugs and product candidates. 
 
“We are very excited about these results,” said Dr. Ge Li, chairman and chief executive officer of WuXi PharmaTech. “At WuXi, we are always seeking cutting-edge solutions like TruTags to help support the development and protection of our customers’ innovative products.”
 
Kent Mansfield, president of TruTag Technologies, said, “We are excited to confirm these results in testing conducted with our partner WuXi PharmaTech, an innovative company that values its customers’ IP and patients’ safety.  We have demonstrated the ability of our technology to integrate an edible and safe identification code directly into an oral solid drug, thereby indelibly marking the product with an internal code for its lifetime.  In the near term, this will allow drug manufacturers and distributors to have the ultimate audit of a drug’s provenance and origin without reliance on packaging or lab chemical analysis.”